Latest stories on SCNX
Scienture Holdings, Inc. (SCNX) files 8-K
SEC 8-K50 · neutralgeneral
Scienture Holdings, Inc. (SCNX) Shareholder/Analyst Call Prepared Remarks Transcript
Seeking Alpha50 · neutralgeneral
Scienture price target lowered to split-adjusted $6 at Maxim
The Fly34 · bearishanalyst
Scienture Holdings, Inc. (SCNX) files 8-K
SEC 8-K42 · neutralgeneral
Scienture Holdings reports preliminary Q3 results
Business Insider74 · bullishearnings
Scienture Posts Preliminary Q3 Revenue of About $1.22 Million as REZENOPY Launch Adds a Second Commercial Product
October 13, 2026
MarketChameleon67 · bullishearnings
SCIENTURE Reports Approximately $1.22 Million in Unaudited Preliminary Q3 2026 Revenue, Achieving 256% Sequential Growth
Business Insider74 · bullishearnings
SCIENTURE Reports Approximately $1.22 Million in Unaudited Preliminary Q3 2026 Revenue, Achieving 256% Sequential Growth
GlobeNewswire74 · bullishearnings
Scienture Holdings, Inc. (SCNX) files 8-K
SEC 8-K50 · neutralgeneral
Scienture Holdings Inc trading halted, news pending
The Fly48 · neutralgeneral
Scienture Holdings Inc trading halted, news pending
Business Insider48 · neutralgeneral
SCNX Highlights Pediatric Hospital Formulary Additions as Arbli Targets a $219 Million Losartan Market
MarketChameleon67 · bullishproduct/pr
Scienture’s Arbli added to formularies at 3 U.S. pediatric academic med centers
The Fly63 · neutralproduct/pr
SCIENTURE Announces Arbli™ Added to Formularies at Three Leading U.S. Pediatric Academic Medical Centers and Hospitals
GlobeNewswire67 · bullishproduct/pr
SCIENTURE Announces Arbli™ Added to Formularies at Three Leading U.S. Pediatric Academic Medical Centers and Hospitals
Business Insider67 · bullishproduct/pr
Scienture announces reverse stock split
The Fly25 · bearishgeneral
Scienture announces 1-for-25 reverse stock split
Seeking Alpha25 · bearishgeneral
Scienture Holdings, Inc. Announces Reverse Stock Split
GlobeNewswire25 · bearishgeneral
Scienture Holdings, Inc. Announces Reverse Stock Split
Business Insider38 · neutralgeneral
Scienture (SCNX) Locks in Exclusive Distribution Channel for REZENOPY Across About 2,000 Opioid Treatment Program Clinics
September 22, 2026
MarketChameleon67 · bullishproduct/pr
Scienture expands commercial reach of Rexenopy to Addiction Treatment Centers
The Fly63 · neutralproduct/pr
SCIENTURE Expands Commercial Reach of REZENOPY™ to Addiction Treatment Centers through an Agreement with a Distribution Partner
Business Insider63 · neutralproduct/pr
SCIENTURE Expands Commercial Reach of REZENOPY™ to Addiction Treatment Centers through an Agreement with a Distribution Partner
GlobeNewswire63 · neutralproduct/pr